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BACKGROUND፡ The majority of population rely on traditional 
medicine as a source of healthcare. Artemisia afra is a plant 
traditionally used for its medicinal values, including treatment of 
malaria in many parts of the world. Currently, it is also attracting 
attention because of a claim that a related species, Artemisia 
annua, is a remedy for the COVD-19 pandemic. The aim of the 
present study was to investigate toxic effects of A. afra on brain, 
heart and suprarenal glands in mice aged 8-12 weeks and 
weighing 25-30g. 
METHODS: Leaves of A.afra were collected from Bale National 
Park, dried under shade, crushed into powder and soaked in 
distilled water to yield aqueous extract for oral administration. 
For acute toxicity study, seven treated and one control groups, 
with 3 female mice each, were used. They were given a single 
dose of 200mg/kg, 700mg/kg, 1200mg/kg, 2200mg/kg, 3200mg/kg, 
4200mg/kg or 5000mg/kg b/wt of the extract. For the sub-acute 
toxicity study, two treated and one control groups, with 5 female 
and 5 male mice each, were used.  They were daily treated with 
600mg/kg or 1800mg/kg b/wt of extract. 
RESULTS: LD50 was found to be greater than 5000mg/kg 
indicating that the plant is relatively safe. In the sub-acute study, 
no signs of toxicity were observed in all treatment groups. On 
microscopic examination of the brain, heart and suprarenal 
glands no sign of cellular injury was observed.  
CONCLUSION: The findings of this study suggest that the leaves 
extract of A. afra is relatively safe in mice. 
KEYWORDS: A. afra, Toxicity study, histopathology, brain, 




The genus Artemisia, which belongs to the family of Asteraceae, 
contains more than 400 species and is widely used in many parts of 
the world either alone or in combination with other plants as herbal 
remedy for a variety of human ailments. A. afra is a medium-size 
perennial herb, rarely exceeding 2m high. It is located in Ethiopia
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Kenya, Zimbabwe, Malawi, Angola and South 
Africa (1).  
Various parts of the plant contain volatile 
oil, terpenoids, coumarins, acetylenes, 
scopoletin and flavonoids (2). The volatile oil 
contains 1, 8-cineole, α-thujone, β-thujone, 
camphor and borneol, and has definite anti-
microbial and anti-oxidative properties. Thujone 
is known to cause neurotoxicity with different 
neurological symptoms like dizziness, tremor, 
convulsion and hallucination (3).  
Artemisia species are most commonly 
used in traditional folk medicine, notably in the 
treatment of malaria. In Ethiopia, A. afra is 
traditionally used in combination with other 
herbals as a remedy against headache, eye 
diseases, ringworm, haematuria and stabbing 
pain (4).  It is also used to treat infertility, febrile 
illness, common cold, spirit and epilepsy (5).   
A. afra has recently attracted worldwide 
attention of researchers for its possible use in the 
treatment of chronic diseases like diabetes, 
cardiovascular diseases and cancer. Aqueous 
extract of A. afra has cardioprotective, 
antihyperlipidemic, antioxidant and 
antihypertensive activities (6). Its related species 
A. annua is recently claimed from Madagascar 
to be a remedy for the current COVID-19 
pandemic. Ethanol extract of A. afra was 
observed to arrest cell cycle of cancer cells (7). 
Aqueous extract of A. afra was shown to 
decrease glucose level near normal range and to 
have antioxidant activity in diabetic rats (8). It 
was also reported that it has bronchodilation and 
anti-inflammatory activities (9). 
Whilst evidence-based studies indicating 
the efficacy of herbal remedies are still being 
unveiled, increasing evidence regarding adverse 
effects of herbal medicine has highlighted the 
demand for toxicological studies for herbal 
products (10). This could also be true for A. afra 
with only limited studies have investigated its 
toxicity. Acute oral administration of aqueous 
extract of A. afra to mice was non-toxic with 
LD50 of 8960mg/kg (2). The same study showed 
that chronic oral administration of this extract in 
rats was relatively safe with minor intermittent 
diarrhea, salivation and partial hypo-activity. 
Acute and sub-chronic toxicity studies on the 
aqueous leaf extract of A. afra have also shown 
no significant sign of toxicity on liver, kidney 
and some blood parameters in Wistar rats (11). 
However, studies on the effect of the plant 
extract on other vital organs are lacking. The 
aim of the present study was to investigate toxic 
effects of A. afra on brain, heart and suprarenal 
glands in albno mice.  
 
MATERIALS AND METHODS 
 
The study was laboratory based experiment 
conducted at Addis Ababa University (AAU), 
College of Health Sciences, Departments of 
Anatomy and Physiology, and Ethiopian Public 
Health Institute (EPHI) from September 2014 to 
July, 2015.  
Collection of plant materials: A. afra was 
collected from Bale National Park, 400km 
southeast of Addis Ababa in Oromia regional 
state during the month of September 2014. The 
plant was identified by a taxonomist, and a few 
samples were deposited at the National 
Herbarium in the College of Natural and 
Computational Sciences, Addis Ababa 
University (AAU), with a voucher specimen 
number of 392/NKI/PHARM. 
Preparation of aqueous leaf extract: The plant 
leaves were cleaned, dried in shade, ground to 
powder (400g) and macerated with distilled 
water for 2hrs and 30minutes with intermittent 
agitation by orbital shaker. The supernatant part 
of agitated materials was decanted and filtered 
with 0.1 mm2 mesh gauze from the un-dissolved 
portion of the plant. The filtrate was freeze-dried 
to give 43g (10.75% yield) of crude extract. 
Experimental animals: The animals used in 
this study were bred and reared at the animal 
house of EPHI and transported to AAU, College 
of Health Sciences, Department of Physiology. 
Experiments were conducted on 54 healthy adult 
male and female mice aged 8-12 weeks and 
weighing 25-30g. Grouping of mice was done 
randomly. The animals were kept in separate 
polycarbonate cages and provided with bedding 
of clean paddy husk. The mice were 
acclimatized to laboratory conditions for one 
week prior to experimentation to minimize 
nonspecific stress (12).  
The test substance was administered in single 
and repeated doses by gavages for acute and 
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sub-acute toxicity studies, respectively. For the 
acute toxicity study, prior to dosing food but not 
water was withheld for 3 hours.  Following the 
period of fasting, the animals were weighed, and 
the dose was calculated according to the body 
weight for each animal. The test substance 
dissolved in distilled water was then 
administered.  After the substance was 
administered, food was withheld for 2 hours 
(12). 
Acute toxicity study and LD50 determination: 
Acute toxicity test was done as per the OECD 
guideline for testing of chemicals 423 (12). It 
was started with low initial single dose of 
200mg/kg. This dose was selected in reference 
to a previous efficacy study of A. afra which 
showed significant anti-diabetic activity at 
200mg/kg in diabetic rats (13). Additional six 
higher single doses of 700mg/kg, 1200mg/kg, 
2200mg/kg, 3200mg/kg, 4200mg/kg and 
5000mg/kg were administered. A total of eight 
groups of mice were used (seven treated and one 
control) each consisting of 3 female adult albino 
Swiss mice.  
The treated and control groups were 
observed continuously for 3hrs and then every 
24hrs for the next 14 days; and any signs of 
toxicity and mortality were recorded. The 
presence or absence of toxic signs like increased 
motor activity, tremors, ptosis, lacrimation, 
exophthalmos, piloerection, salivation and 
depression were observed during the study 
period. The body weight of each mouse was 
recorded at the 7th and 14th days. The differences 
in the body weight were also recorded.  
Lethal doses for fifty percent of the mice 
(LD50) for aqueous leaf extracts of A. afra were 
determined using Protocol for LD50 
determination (12). On the 14th day of treatment, 
all mice were sacrificed with anesthetic diethyl 
ether. Comprehensive gross pathological 
observations were carried out on the brain, heart 
and suprarenal glands to check for any signs of 
abnormality and presence of lesions.   
Sub-acute toxicity study: The study was carried 
out using 15 female and 15 male mice which 
were grouped into six groups, 3 groups for the 
females and another three groups for the males. 
For both sexes, two groups were given 
600mg/kg (low dose) and 1800mg/kg (high 
dose) of the extract for 28 days, while another 
group was given vehicle (distilled water). The 
low dose was selected in reference to an efficacy 
study of A. afra in treatment of malaria which 
showed 400 mg/kg as effective dose (14). 
However, this dose was modified to 600 mg/kg 
based on clinical observation of acute toxicity 
studies (15). The volume of the extract and 
distilled water was calculated as 1.5ml/100g and 
given at constant time between 9:00-10:00 am 
once a day. 
Individual weights of mice were taken 
shortly before the test substance was 
administered and weekly thereafter using digital 
electronic balance. Weight changes were also 
calculated and recorded.  Mice were observed 
individually once during the first 30 minutes 
after dosing, four times for the first 4 hours with 
one hour interval and daily thereafter for 28 
days.  Clinical observation for morbidity and 
mortality once a day  were recorded (15). 
For screening possible neurobehavioral 
toxicity, in cage and open field observations 
were done daily. Functional observational 
battery was employed to assess a wide range of 
neurobiological functions, including sensory, 
motor and autonomic components. In the present 
study, functional observational battery 
comprising a series of assessments designed to 
measure motor, sensory and autonomic function 
was used (16). These included posture, abnormal 
motor activity (like tremor and fasciculation, 
convulsion), ease of removal from cage, 
reactivity to handling, lacrimation anorexia and 
salivation. 
At the end of the test, animals were 
weighed and then humanely sacrificed 
anesthetizing with  diethyl ether (15). Organs of 
interest; namely, the brain, heart and suprarenal 
glands were carefully dissected out and weighed. 
The relative organ weights of heart and brain 
were calculated using the animal weight as a 
denominator, while that of the suprarenal 
glands’ was calculated using the brain as a 
denominator.   
Gross pathological examinations for 
toxicological lesions, including the presence of 
dark and white spot and necrosis were done. For 
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the brain, frontal lobes of cerebrum were taken 
by coronal section at the level of Bregma. Both 
the right and left suprarenal glands were taken as 
a sample. The heart was sectioned longitudinally 
through ventricle and atria from the base to the 
apex, and the left atria and ventricle were taken 
for histopathological investigation. Sample 
tissues were taken and placed in a labeled test 
tube containing 10% buffered formalin. Fixed 
tissues were dehydrated and cleared, 
respectively, in ascending graded series of 
ethanol and xylene, infiltrated with molten 
paraffin wax and embedded in paraffin blocks. 
These were sectioned at a thickness of 5µm 
using Leica rotary microtome (LEICA RM 2125 
RT, Germany). Ribbons of tissue sections were 
gently collected and placed onto the surface of a 
water bath heated at 400C. They were then 
collected onto gelatin coated glass slides and 
placed in oven overnight. Sections were 
deparaffinized by xylene, hydrated through a 
down series of alcohols, and stained by Harris’ 
hematoxylin. Slides were differentiated by 1% 
acid alcohol and counter stained in eosin. 
Stained sections were dehydrated with 
increasing concentrations of ethyl alcohols and 
cleared in xylene, mounted using DPX and 
covered with cover slips. 
Stained tissue sections of brain, heart and 
suprarenal glands were carefully examined 
under binocular compound light microscope 
(LEICA DM 750, Germany). Tissue sections 
from the treated groups were examined for any 
evidence of histopathological changes by a 
pathologist with respect to those of the controls 
blindly. After examination, photomicrographs of 
selected sample sections of brain, heart and 
suprarenal glands from both treated and control 
mice were taken under a magnification of x20 
objective by using automated built-in digital 
photo-camera (EVOS XL, USA). 
Data processing and analysis: All quantitative 
data were organized and analyzed using 
Statistical Package for Social Science (SPSS) 
version 21 statistical software. The values of 
body and organ weight including relative organ 
weights were analyzed, and the results were 
expressed as mean ±SEM (standard error of 
mean). Difference between treated and control 
groups were compared using one-way ANOVA.  
P-values <0.05 were considered statistically 
significant.  
Ethical approval: Ethical approval was 
obtained from the Research Review Committee 
of the Department of Anatomy, College of 
Health Sciences, AAU. 
 
RESULTS 
Acute toxicity study: The single oral 
administration of aqueous extract of A. afra in 
mice did not show any mortality even with the 
highest dose which was 5000mg/kg. No signs of 
toxicity were observed at the lower four doses, 
i.e., 200mg/kg, 700mg/kg, 1200mg/kg and 
2200mg/kg. However, signs of mild toxicity like 
anxiety and piloerection were seen at the doses 
of 3200, 4200mg/kg and 5000mg/kg. These 
symptoms gradually disappeared after some 
wash out periods over two weeks observation.  
Moreover, there was a gradual increase in body 
weight of treated mice though not statistically 
different among the different groups.  
Sub-acute Toxicity 
Effects of A. afra aqueous leaves extract on 
behavior and body weight of mice: During the 
period of 28 days of sub-acute toxicity study, 
mice treated orally with both low and high doses 
of the extract showed no noticeable change in 
their general behavior compared to the control 
group. There was also no significant difference 
between the two sexes, except that the males, in 
both treated and non-treated control groups, 
were more aggressive compared to the females 
(Table 1). Moreover, there was no toxicity 
related death throughout the period of the study. 
Gradual weight gain was observed in both 
treated and control groups though not 
statistically significant during the study period, 
and no significant difference was also observed 
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Table 1: Neurobehavioral neurotoxicity evaluation of male and female mice treated with aqueous extract 
of A. afra as compared to the controls during consecutive four weeks of observations. 
 
Neurologic symptom & sign 
                       Male                  Female  
600mg/kg 1800mg/kg Control  600mg/kg 1800mg/kg Control  
Ataxia/abnormal gait        -        - - - - - 
Hunched posture         -        - - - - - 
Pain response (tail pinch)        +       + + + + + 
Convulsions        -        - - - - - 
Depression of open field activity        -        - - - - - 
Anorexia         -        - - - - - 
Irritability/aggressiveness       +       + + - - - 




Figure 1: Mean body weight growth between female (A) and male (B) mice treated with 600mg/kg and 
1800mg/kg of aqueous leaves extract of A.afra as compared to the controls. Values are m+/-SEM. n=5. 
 
Effects of A. afra aqueous leaves extract on 
gross pathology and relative organ weight: On 
gross examination of brain, heart and suprarenal 
glands, no abnormal gross pathological findings 
like dark and white spot and necrosis were 
observed in any of the treatment and control 
groups. There were no significant absolute and 
relative organ weight changes between treated 
and control groups in both sexes (Table2). 
Effects of aqueous leaves extract on histology 
of cerebral cortex, heart and suprarenal 
glands: Microscopic examination of cerebral 
cortex of mice treated with 600mg/kg and 
1800mg/kg of aqueous leaves extract of A. afra 
indicated no structural disturbance compared to 
the controls. No signs of individual neuron death 
and focal lesion such as pyknosis, karyorrhexis 
and karyolysis and eosinophilic cytoplasm were 
observed in both male and female mice. In 
addition, no sign of inflammation like 
lymphocytic infiltration were observed in male 
and female mice (Figure 2). The cyto-
architecture of cerebral cortex was identical 
between treated and control mice. 
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Table 2: Absolute and relative organ weights of mice orally treated with 600mg/kg and 1800mg/kg of 
aqueous leaves extract of A. afra as compared to the controls. 
 
Group  













Male   
600 mg/kg/day  0.43±0.02 1.21±0.02 0.15±0.01 0.42±0.02 0.01±0.002 2.32±0.003 
1800 mg/kg/day 0.44±0.01 1.19±0.03 0.17±0.01 0.46±0.01 0.01±0.004 2.27±0.004 
Control  0.44±0.2 1.2±0.02 0.15±0.01 0.41±0.01 0.01±0.003 2.27±0.004 
Female  
600 mg/kg/day  0.43±0.02 1.26±0.02 0.15±0.007 0.44±0.01 0.01±0.001 2.32±0.001 
1800 mg/kg/day 0.45±0.003 1.16±0.02 0.16±0.02 0.41±0.008 0.01±0.002 2.22±0.001 
Control 0.45±0.002 1.2±0.04 0.15±0.003 0.41±0.004 0.01±0.004 2.22±0.001 





Figure 2: Photomicrographs of H & E stained sections of cerebral cortex from female mice treated with 
aqueous leaves extract of A. afra at 600mg/kg (B) and 1800mg/kg (C) as compared to the control (A); I = 
Molecular, II/III = Supragranular Pyramidal, IV = Granular, V = Deep Pyramidal and VI = 
Polymorphic (Multiform) layers. Magnifications X200 
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No architectural difference was observed in 
microscopic examination of the heart of treated 
and control female and male mice. In mice 
treated with both 600mg/kg and 1800mg/kg of 
the extract, no signs of myocardial cell injury 
such as pyknosis, karyorrhexis, karyolysis, 
vacuolation, focal necrosis and fibrosis were 
observed. Furthermore, no sign of inflammation 
(leukocytic infiltration) was observed in female 




Figure 3: Photomicrographs of H & E stained sections of  heart from female mice treated with aqueous 
leaves extract of A. afraat 600mg/kg (B) and 1800mg/kg (C) as compared to the control (A).  
Magnifications X300 
 
On examination of the sections of suprarenal 
glands, no signs of toxicity were observed 
on both cortical and medullary regions. The 
architecture of both cortex and medulla of 
mice treated with 600mg/kg and 1800mg/kg 
of the extract was identical with that of the 
control. In both treated and control mice, 
two cortical zones were observed with some 
mice showing additional zone (X-zone). 
However, no cortical lesion like 
degeneration (vacuolar or granular), necrosis 
or hemorrhage was observed (Figure 4).  
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Figure 4: Photomicrographs of H & E stained sections of suprarenal glands from female mice 
treated with aqueous leaves extract of A. afra at 600mg/kg (B) and 1800mg/kg (C) as compared 
to the control (A); G = zona golerulosa, F = zona fasciculate, X =  x zone and M = adrenal 
medulla; Magnifications X200  
DISCUSSION 
 
Evaluation of the pathological alterations 
induced in laboratory animals by novel 
treatment agents represents one of the safety 
assessments prior to conducting clinical trials. 
This preliminary assessment represents major 
contributions to the development of new 
treatments for humans and animals. Acute 
toxicity tests provide data on the relative toxicity 
likely to arise from a single or brief exposure. It 
is an initial assessment of toxic manifestations 
induced with the test substance/s (17). 
This study showed that the LD50 of the 
aqueous extract of A. afra was above 5000mg/kg 
which is grouped under category 5 or 
unclassified according to Globally Harmonized 
Classification System (13). This is in agreement 
with the findings of previous studies in mice (2) 
and rats (11) experiments. Oral administrations 
of the extract up to dose of 2200 mg/kg did not 
cause any alteration in the behavioral pattern of 
the mice as compared to the control group. 
However, mild sign of toxicity was observed at 
the higher three doses. There was no significant 
difference in weight gain between treated and 
control groups. Gross examination of heart, 
suprarenal glands and brain revealed no 
treatment-related gross findings at necropsy. The 
results of acute toxicity test in this study, 
therefore, indicate that aqueous leaf extract of A. 
afra is tolerated up to the limit of 5000mg/kg 
body weight as per OECD guidelines (12).  
Sub-acute toxicity study provides 
information on possible health hazards likely to 
occur on nervous, immune and endocrine 
systems from repeated exposure over a relatively 
limited period of time (15). The present sub-
acute toxicity study with oral aqueous extract of 
A. afra on body weight, brain, heart and 
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suprarenal glands showed that no significant 
behavioral changes were observed between 
treated and control groups in both sexes. 
Changes in animals’ body weights are usually 
used as an indicator of toxic effects of test 
substances (18). On the other hand, increase in 
animals’ body weight could also be related to 
body fat accumulation rather than to toxicity 
(19). The non-significant increase in body 
weight observed in the present study might be 
attributed to fat accumulation in the body. 
Evaluation of organ-to-body weight and organ-
to-brain weight ratios are also used to assess 
treatment related effects in toxicological studies. 
For suprarenal glands, organ-to-brain ratio is 
more predictive of suprarenal glands weight 
change than organ-to-body weight ratio (20). No 
significant changes were observed in absolute 
and relative organ weights of all groups in the 
present study (21). These findings are in line 
with those of previous studies done with other 
species of the genus Artemisia 
In  response  to  injury,  a number  of  
changes  may occur  in  neurons  and  their  
processes (axons  and  dendrites) like shrinkage 
of cell body, pyknosis of the nucleus, 
disappearance of the nucleolus and loss of Nissl 
substance with intense eosinophilia of the 
cytoplasm (red neurons) (22). In the 
histopathological examination of cerebral cortex, 
none of these morphological changes was 
observed which was supported by absence of 
abnormal behavior and motor activity on cage 
side observation. This might suggest that the 
aqueous leaf extract of A. afra may not cause 
toxicity to cerebral cortex of mice. 
Because of its high oxidative metabolic 
need, the heart can be injured by any compounds 
that interfere with its oxygen supply. On 
microscopic examination, myocardial damage 
can take the form of cytoplasmic alterations such 
as vacillation, pyknotic nucleus, karyrrhexis, and 
karyolysis in diffuse or localized area (23). In 
the present study, none of these lesions were 
observed which is in line with the results of the 
previous study done on the same plant with 
different dose (2).  
Suprarenal glands are reported to be the 
most common endocrine organ associated with 
chemically induced lesions (24). These lesions 
are more frequent in the zona fasciculata than in 
the zona glomerulosa. The adrenal cortex 
produces steroid hormones with a 17-carbon 
nucleus following a series of hydroxylation 
reactions that occur in the mitochondria and 
endoplasmic reticulum. Toxic agents for the 
adrenal cortex include short-chain aliphatic 
compounds, lipidosis inducers, amphiphilic 
compounds, natural and synthetic steroids, and 
chemicals that affect hydroxylation (25). 
Morphologic evaluation of cortical lesions 
provides insight into the sites of inhibition of 
steroidogenesis. In the present study, no 
histological degenerative or proliferative lesions 
of cortex or medulla were observed suggesting 
the non-toxic effect of the plant on the glands 
which is in agreement with that of the previous 
study done in other species of the same genus 
(21).  
In conclusion, the present findings suggest 
that administration of 600mg/kg and 1800mg/kg 
of body weight of aqueous leaves extract of A. 
afra in mice for a month is safe. 
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